TCL Archive Bypass Budget For FY Seeks $1.189 Billion, Would Fund 1,018 Competing Grants, Restore Cuts May 20, 1983
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan. March 11, 2005